Dr Ricardo Rendon


Email: rrendon@dal.ca
Phone: 902-425-3940
Fax: 902-422-0033
Mailing Address: 
5991 Spring Garden Road
Suite 620
Halifax, Nova Scotia
B3H 1Y6
Research & Clinical Interests:
  • Urologic cancer
  • Urologic surgery
  • Minimally invasive surgery
  • Surgery techniques
  • Kidney cancer

Recent Publications

Google Scholar

Gillis, Charlie J., Ali Sherazi, Ricardo A. Rendon, Gabriela Ilie, and Ross Mason. “Examining the Utility of Routine Perioperative Hemoglobin Monitoring in Patients Undergoing Radical Nephrectomy.” Canadian Urological Association Journal 18, no. 6 (2024). https://cuaj.ca/index.php/journal/article/view/8603.

Lawen, Tarek, Gabriela Ilie, Ross Mason, Ricardo Rendon, Jesse Spooner, Emmi Champion, Jessica Davis, Cody MacDonald, Michael J. Kucharczyk, and Nikhilesh Patil. “Six-Month Prostate Cancer Empowerment Program (PC-PEP) Improves Urinary Function: A Randomized Trial.” Cancers 16, no. 5 (2024): 958.

MacDonald, Landan, Ricardo A. Rendon, Myuran Thana, Lori Wood, Robyn MacFarlane, David Bell, Jonathan Duplisea, and Ross Mason. “An In-Depth Analysis on the Effects of Body Composition in Patients Receiving Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma.” Canadian Urological Association Journal 18, no. 6 (2024). https://cuaj.ca/index.php/journal/article/view/8542.

In the News

Dr. Rendon is often contacted my media outlets to provide his expert opinion on a variety of topics such as prostate-specific membrane antigen (PSMA), a new treatment for metastatic castration-resistant prostate cancer (MCRPC) with PSMA expression, and to explain MCRPC in more accessible language. Dr. Rendon also speaks on bladder cancer and the innovative use of robotics in surgery for kidney cancer.  


  • MD (Universidad Javeriana, Bogota, Colombia)
  • Internship (Universidad Javeriana, Bogota, Colombia)
  • Residency (Universidad Javeriana, Bogota, Colombia)
  • Research and Clinical Fellowship (Princess Margaret Hospital and University of Toronto)
  • MSc, Community Health & Epidemiology (Dalhousie University)



Current Department Roles

  • Director of Research, Department of Urology, Dalhousie University
  • Director, Clinical Trials Program, Department of Urology, Dalhousie University
  • Coordinator, Department of Urology Research Rounds, Dalhousie University
  • Member, Residency Program Committee, Department of Urology (VG Site Coordinator)
  • Urological Oncology Research


Dr. Ricardo Rendon did his medical school and residency in Bogota, Colombia. He subsequently completed a clinical and research UroOncology Fellowship at the University of Toronto, Canada and a Masters in Community Health Clinical Epidemiology. He joined Dalhousie University in Halifax, Canada in 2001 where he is a Professor in the Department of Urology and the Director of Research and Clinical Trials. He is the Chair of the Genito-Urinary Cancer Site Team, Nova Scotia Health Authority Cancer Program. Dr. Rendon is currently the Vice-President of Education of the Canadian Urological Association and Chair of the Canadian Urologic Oncology Group. While his clinical practice focuses on all areas of urologic oncology, his research focuses on renal cell carcinoma, advanced prostate cancer and urothelial cell carcinoma. He has authored over 184 peer-reviewed manuscripts and has been particularly active in the development of clinical guidelines and national and international collaborations in kidney, bladder, upper tract urothelial cell carcinoma and prostate cancer.